NPDK-18

N/A

Report date: 2025/01/15 20:00:32
NME

Base Information

Drug NameNPDK-18
Drug Alias NameNPDK-18
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 12 inhibitorsMatrix metalloproteinase 9 inhibitorsMatrix metalloproteinase-1 inhibitors +[6] 
TargetsMatrix metalloproteinase 13Matrix metalloproteinase 12Matrix metalloproteinase-2 +[6] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRiken
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRiken
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A